|

Our firm provides a
number of consulting services, which are described in
detail under the WebPages shown above. A short
description of each is listed below:
 |
Facility Design Services
- Our firm has completed
conceptual facility design plans for 40
manufacturing facilities, including 30 facilities
for cell and gene therapy products. We work
with our clients to define their specific needs and
to provide a facility design optimized for those
needs that also meets FDA cGMP/QSR/GTP requirements,
as appropriate. |
 |
Manufacturing
Services - Assistance is provided for research,
development, scale-up, and clinical and commercial
stages of production. Technology
analysis/evaluation, production problem-solving and
regulatory compliance programs are included. |
 |
Quality
Services - Support is provided for the development of
quality systems and for assessment/oversight of
pre-clinical, clinical and commercial manufacturing, as required for regulatory compliance. |
 |
Audit Services
- We conduct vendor audits, contract manufacturer
and testing laboratory audits and provide development
assistance/assessment for
internal audit programs. |
 |
Training
Services - cGMPs, GTPs, QSRs and GLPs require
annual training on the specific regulations for all
manufacturing/testing employees, as well as
job-specific training on operational procedures and
document systems. Introductory and annual
training on the appropriate regulations are provided
in sessions tailored to each client's specific
needs. Development and assessment of
job-specific training programs may also be
furnished. |
 |
Due Diligence
Services - Interactions between various
organizations that involve mergers, acquisitions,
significant investments, technology transfers,
transfer of product assets or intellectual property,
etc. generally require assessment by outside experts
to ensure compliance with the acquiring company's
fiduciary responsibilities. Our firm provides
this expertise in manufacturing, quality and
manufacturing associated regulatory areas. |
 |
FDA / CMC
Services - Interactions with the FDA and
submission of marketing applications generally fall
under the purview of the Regulatory Affairs
department in most organizations. Our firm
provides expertise for those regulatory areas that
involve manufacturing and/or technology issues.
We participate in FDA meetings where these issues
are discussed. We generally take the lead role
during FDA facility related meetings, when our
facility design is reviewed by the agency. |
In addition we
prepare and/or review CMC (Chemistry, Manufacturing
and Control) sections of IND, IDE, BLA, NDA, and PMA
documents and their amendments for submission to the
FDA.
Top of Page
|